Chargement en cours...
TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells
BACKGROUND: CD44 is a molecular marker associated with cancer stem cell populations and treatment resistance in glioma. More effective therapies will result from approaches aimed at targeting glioma cells high in CD44. METHODS: Glioma-initiating cell lines were derived from fresh surgical glioblasto...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Oxford University Press
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3779037/ https://ncbi.nlm.nih.gov/pubmed/23877317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not079 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|